EGFR and non-small cell lung carcinoma: Analysis of single-cell RNA sequencing data from NSCLC clinical samples reveals that in tumors undergoing EGFR-TKI treatment, the expression of A3B mRNA, along with NF-κB components RELA and RELB, rises significantly, particularly during the disease progression phase.